论文信息 - Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody - 字舞流文

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

M. Tomonaga | Yasuaki Yamada | M. Tawara | T. Maeda | R. Yamasaki | C. Tsutsumi | Y. Onimaru | Y. Yakata | S. Kamihira | Reishi Yamasaki